Management of Atopic Dermatitis Methods and Challenges /
This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focus...
محفوظ في:
| مؤلف مشترك: | |
|---|---|
| مؤلفون آخرون: | , , |
| التنسيق: | الكتروني كتاب الكتروني |
| اللغة: | الإنجليزية |
| منشور في: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| الطبعة: | 2nd ed. 2024. |
| سلاسل: | Advances in Experimental Medicine and Biology,
1447 |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1007/978-3-031-54513-9 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-54513-9 | ||
| 003 | DE-He213 | ||
| 005 | 20260810115410.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240509s2024 sz | o |||| 0|eng d | ||
| 020 | |a 9783031545139 |9 978-3-031-54513-9 | ||
| 024 | 7 | |a 10.1007/978-3-031-54513-9 |2 doi | |
| 050 | 4 | |a RL1-803 | |
| 072 | 7 | |a MJK |2 bicssc | |
| 072 | 7 | |a MED017000 |2 bisacsh | |
| 072 | 7 | |a MJK |2 thema | |
| 082 | 0 | 4 | |a 616.5 |2 23 |
| 245 | 1 | 0 | |a Management of Atopic Dermatitis |h [electronic resource] : |b Methods and Challenges / |c edited by Steven R. Feldman, Lindsay C. Strowd, Katie K. Lovell. |
| 250 | |a 2nd ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 online resource (X, 248 p. 9 illus.). |b 7 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1447 | |
| 505 | 0 | |a Introduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs).-Introduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs) -- Systemic Biologic Management (dupilumab and tralokinumab) -- Non-Prescription Treatment Options -- Adherence in Atopic Dermatitis -- Atopic Dermatitis: Managing the Itch -- Atopic Dermatitis Disease Education -- Guidelines from American Academy of Dermatology -- The Future of Atopic Dermatitis Treatment (to be updated—some drugs discussed in this chapter are now FDA approved). | |
| 520 | |a This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment. This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families, assessing patient compliance, and patient resources. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Dermatology. | |
| 650 | 0 | |a Epidemiology. | |
| 650 | 0 | |a Pathology. | |
| 650 | 1 | 4 | |a Dermatology. |
| 650 | 2 | 4 | |a Epidemiology. |
| 650 | 2 | 4 | |a Pathology. |
| 700 | 1 | |a Feldman, Steven R. |e editor. |0 (orcid)0000-0002-0090-6289 |1 https://orcid.org/0000-0002-0090-6289 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Strowd, Lindsay C. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Lovell, Katie K. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031545122 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031545146 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031545153 |
| 830 | 0 | |a Advances in Experimental Medicine and Biology, |x 2214-8019 ; |v 1447 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-54513-9 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||